Glatiramer acetate therapy for multiple sclerosis: a review.
about
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribineAutoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.Biodegradable polymers derived from amino acids.The role of glatiramer acetate in the early treatment of multiple sclerosisThe results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.An urticarial vasculitis case induced by glatiramer acetate.
P2860
Glatiramer acetate therapy for multiple sclerosis: a review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glatiramer acetate therapy for multiple sclerosis: a review.
@ast
Glatiramer acetate therapy for multiple sclerosis: a review.
@en
type
label
Glatiramer acetate therapy for multiple sclerosis: a review.
@ast
Glatiramer acetate therapy for multiple sclerosis: a review.
@en
prefLabel
Glatiramer acetate therapy for multiple sclerosis: a review.
@ast
Glatiramer acetate therapy for multiple sclerosis: a review.
@en
P2093
P2860
P1476
Glatiramer acetate therapy for multiple sclerosis: a review
@en
P2093
Alexandros Tselis
Corey Ford
Jai Perumal
Kenneth Johnson
Luanne Metz
Mark Tullman
Robert Lisak
P2860
P304
P356
10.1517/17425255.2.6.1019
P407
P577
2006-12-01T00:00:00Z